Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Article

Industry Collaboration International Collaboration

cited authors

  • Cosentino, Francesco; Cannon, Christopher P.; Cherney, David Z. I.; Masiukiewicz, Urszula; Pratley, Richard; Dagogo-Jack, Sam; Frederich, Robert; Charbonnel, Bernard; Mancuso, James; Shih, Weichung J.; Terra, Steven G.; Cater, Nilo B.; Gantz, Ira; McGuire, Darren K.; VERTIS CV Investigators

authors

Publication Date

  • December 8, 2020

webpage

published in

category

keywords

  • cardiovascular diseases
  • diabetes mellitus, type 2
  • heart failure
  • sodium-glucose cotransporter 2 inhibitors

start page

  • 2205

end page

  • 2215

volume

  • 142

issue

  • 23